Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.

Tyagi, Alpna

Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. [electronic resource] - Carcinogenesis Nov 2005 - 1978-87 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

0143-3334

10.1093/carcin/bgi165 doi


Antineoplastic Agents, Phytogenic--pharmacology
Ataxia Telangiectasia--metabolism
Ataxia Telangiectasia Mutated Proteins
CDC2 Protein Kinase--metabolism
Cell Cycle Proteins--metabolism
Checkpoint Kinase 1
Checkpoint Kinase 2
DNA-Binding Proteins--metabolism
Female
Humans
Ovarian Neoplasms--drug therapy
Phosphorylation--drug effects
Protein Kinases--metabolism
Protein Serine-Threonine Kinases--metabolism
Resveratrol
Ribonucleotide Reductases--antagonists & inhibitors
S Phase--drug effects
Signal Transduction--drug effects
Stilbenes--pharmacology
Tumor Cells, Cultured
Tumor Suppressor Proteins--metabolism
Tyrosine--metabolism
cdc25 Phosphatases--metabolism